Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-30 @ 8:45 AM
Study NCT ID:
NCT05865457
Status:
RECRUITING
Last Update Posted:
2025-12-16
First Post:
2023-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
Sponsor:
TRB Chemedica International SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BUFY02-CT-2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None